{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T22:47:51Z","timestamp":1780872471477,"version":"3.54.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,19]]},"DOI":"10.7759\/cureus.84411","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T17:00:21Z","timestamp":1747674021000},"source":"Crossref","is-referenced-by-count":2,"title":["Effects of Small Extracellular Vesicles Derived From Mesenchymal Stromal Cells on Acute Kidney Injury: A Rat Ischemia-Reperfusion Model"],"prefix":"10.7759","author":[{"given":"Shani","family":"Zilberman Itskovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Sova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramzia","family":"Abu-Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Frage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima","family":"Esawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Neuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lital","family":"Sela-Tzuriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimon","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shai","family":"Efrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01369","article-title":"Mesenchymal stromal cell uses for acute kidney injury-current available data and future perspectives: a mini-review","volume":"11","author":"Zilberman-Itskovich S","year":"2020","unstructured":"Zilberman-Itskovich S, Efrati S. Mesenchymal stromal cell uses for acute kidney injury-current available data and future perspectives: a mini-review. Front Immunol. 2020, 11:1369. 10.3389\/fimmu.2020.01369","journal-title":"Front Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.66.S1.45","article-title":"Mesenchymal stem cell therapy in acute kidney injury (AKI): review and perspectives","volume":"66Suppl 1","author":"S\u00e1vio-Silva C","year":"2020","unstructured":"S\u00e1vio-Silva C, Soinski-Sousa PE, Balby-Rocha MT, Lira \u00c1O, Rangel \u00c9B. Mesenchymal stem cell therapy in acute kidney injury (AKI): review and perspectives. Rev Assoc Med Bras (1992). 2020, 66Suppl 1:s45-54. 10.1590\/1806-9282.66.S1.45","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071619","article-title":"Potential and therapeutic efficacy of cell-based therapy using mesenchymal stem cells for acute\/chronic kidney disease","volume":"20","author":"Yun CW","year":"2019","unstructured":"Yun CW, Lee SH. Potential and therapeutic efficacy of cell-based therapy using mesenchymal stem cells for acute\/chronic kidney disease. Int J Mol Sci. 2019, 20:1619. 10.3390\/ijms20071619","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222354","article-title":"Human mesenchymal stromal cells ameliorate complement induced inflammatory cascade and improve renal functions in a rat model of ischemia-reperfusion induced acute kidney injury","volume":"14","author":"Zilberman-Itskovich S","year":"2019","unstructured":"Zilberman-Itskovich S, Abu-Hamad R, Zarura R, et al.. Human mesenchymal stromal cells ameliorate complement induced inflammatory cascade and improve renal functions in a rat model of ischemia-reperfusion induced acute kidney injury. PLoS One. 2019, 14:e0222354. 10.1371\/journal.pone.0222354","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126596","article-title":"Mesenchymal stem cell-derived extracellular vesicles to the rescue of renal injury","volume":"22","author":"Birtwistle L","year":"2021","unstructured":"Birtwistle L, Chen XM, Pollock C. Mesenchymal stem cell-derived extracellular vesicles to the rescue of renal injury. Int J Mol Sci. 2021, 22:6596. 10.3390\/ijms22126596","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v2i0.21927","article-title":"Extracellular membrane vesicles from umbilical cord blood-derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning","volume":"2","author":"Kilpinen L","year":"2013","unstructured":"Kilpinen L, Impola U, Sankkila L, et al.. Extracellular membrane vesicles from umbilical cord blood-derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning. J Extracell Vesicles. 2013, 2:21927. 10.3402\/jev.v2i0.21927","journal-title":"J Extracell Vesicles"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-017-0727-7","article-title":"Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges","volume":"8","author":"Aghajani Nargesi A","year":"2017","unstructured":"Aghajani Nargesi A, Lerman LO, Eirin A. Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges. Stem Cell Res Ther. 2017, 8:273. 10.1186\/s13287-017-0727-7","journal-title":"Stem Cell Res Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri R","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020, 367:367. 10.1126\/science.aau6977","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2575","article-title":"Concise review: MSC-derived exosomes for cell-free therapy","volume":"35","author":"Phinney DG","year":"2017","unstructured":"Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells. 2017, 35:851-8. 10.1002\/stem.2575","journal-title":"Stem Cells"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms15034142","article-title":"Exosomes derived from mesenchymal stem cells","volume":"15","author":"Yu B","year":"2014","unstructured":"Yu B, Zhang X, Li X. Exosomes derived from mesenchymal stem cells. Int J Mol Sci. 2014, 15:4142-57. 10.3390\/ijms15034142","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02837","article-title":"Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning","volume":"9","author":"Ferreira JR","year":"2018","unstructured":"Ferreira JR, Teixeira GQ, Santos SG, Barbosa MA, Almeida-Porada G, Gon\u00e7alves RM. Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning. Front Immunol. 2018, 9:2837. 10.3389\/fimmu.2018.02837","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101240","article-title":"Stem cell-derived extracellular vesicles and kidney regeneration","volume":"8","author":"Grange C","year":"2019","unstructured":"Grange C, Skovronova R, Marabese F, Bussolati B. Stem cell-derived extracellular vesicles and kidney regeneration. Cells. 2019, 8:1240. 10.3390\/cells8101240","journal-title":"Cells"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2017.04.003","article-title":"Immunomodulatory properties of human placental mesenchymal stem\/stromal cells","volume":"59","author":"Abumaree MH","year":"2017","unstructured":"Abumaree MH, Abomaray FM, Alshabibi MA, AlAskar AS, Kalionis B. Immunomodulatory properties of human placental mesenchymal stem\/stromal cells. Placenta. 2017, 59:87-95. 10.1016\/j.placenta.2017.04.003","journal-title":"Placenta"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123278","article-title":"Mesenchymal stem\/stromal cells derived from human and animal perinatal tissues-origins, characteristics, signaling pathways, and clinical trials","volume":"10","author":"Kulus M","year":"2021","unstructured":"Kulus M, Sibiak R, Stefa\u0144ska K, et al.. Mesenchymal stem\/stromal cells derived from human and animal perinatal tissues-origins, characteristics, signaling pathways, and clinical trials. Cells. 2021, 10:3278. 10.3390\/cells10123278","journal-title":"Cells"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3727\/096368910X","article-title":"Mesenchymal stem cells","volume":"20","author":"Ding DC","year":"2011","unstructured":"Ding DC, Shyu WC, Lin SZ. Mesenchymal stem cells. Cell Transplant. 2011, 20:5-14. 10.3727\/096368910X","journal-title":"Cell Transplant"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3774-5","article-title":"A review of the role of immune cells in acute kidney injury","volume":"33","author":"Bonavia A","year":"2018","unstructured":"Bonavia A, Singbartl K. A review of the role of immune cells in acute kidney injury. Pediatr Nephrol. 2018, 33:1629-39. 10.1007\/s00467-017-3774-5","journal-title":"Pediatr Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"Noris M","year":"2013","unstructured":"Noris M, Remuzzi G. Overview of complement activation and regulation. Semin Nephrol. 2013, 33:479-92. 10.1016\/j.semnephrol.2013.08.001","journal-title":"Semin Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2016.12.017","article-title":"Complement in autoimmune diseases","volume":"465","author":"Vignesh P","year":"2017","unstructured":"Vignesh P, Rawat A, Sharma M, Singh S. Complement in autoimmune diseases. Clin Chim Acta. 2017, 465:123-30. 10.1016\/j.cca.2016.12.017","journal-title":"Clin Chim Acta"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00604.2016","article-title":"Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosis","volume":"312","author":"Xavier S","year":"2017","unstructured":"Xavier S, Sahu RK, Landes SG, et al.. Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosis. Am J Physiol Renal Physiol. 2017, 312:F516-32. 10.1152\/ajprenal.00604.2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2013.08.005","article-title":"The role of the complement system in acute kidney injury","volume":"33","author":"McCullough JW","year":"2013","unstructured":"McCullough JW, Renner B, Thurman JM. The role of the complement system in acute kidney injury. Semin Nephrol. 2013, 33:543-56. 10.1016\/j.semnephrol.2013.08.005","journal-title":"Semin Nephrol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2019.1677248","article-title":"Effect of anti-C5 antibody on recuperation from ischemia\/reperfusion-induced acute kidney injury","volume":"41","author":"Zilberman-Itskovich S","year":"2019","unstructured":"Zilberman-Itskovich S, Abu-Hamad R, Stark M, Efrati S. Effect of anti-C5 antibody on recuperation from ischemia\/reperfusion-induced acute kidney injury. Ren Fail. 2019, 41:967-75. 10.1080\/0886022X.2019.1677248","journal-title":"Ren Fail"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016101150","article-title":"Allogeneic mesenchymal stem cells for treatment of AKI after cardiac surgery","volume":"29","author":"Swaminathan M","year":"2018","unstructured":"Swaminathan M, Stafford-Smith M, Chertow GM, et al.. Allogeneic mesenchymal stem cells for treatment of AKI after cardiac surgery. J Am Soc Nephrol. 2018, 29:260-7. 10.1681\/ASN.2016101150","journal-title":"J Am Soc Nephrol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000492865","article-title":"Eculizumab modifies outcomes in adults with atypical hemolytic uremic syndrome with acute kidney injury","volume":"48","author":"Cao M","year":"2018","unstructured":"Cao M, Leite BN, Ferreiro T, et al.. Eculizumab modifies outcomes in adults with atypical hemolytic uremic syndrome with acute kidney injury. Am J Nephrol. 2018, 48:225-33. 10.1159\/000492865","journal-title":"Am J Nephrol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.11.005","article-title":"Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: case series and review of literature","volume":"49","author":"Kello N","year":"2019","unstructured":"Kello N, Khoury LE, Marder G, Furie R, Zapantis E, Horowitz DL. Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: case series and review of literature. Semin Arthritis Rheum. 2019, 49:74-83. 10.1016\/j.semarthrit.2018.11.005","journal-title":"Semin Arthritis Rheum"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15408","article-title":"Role of intracellular complement activation in kidney fibrosis","volume":"178","author":"Portilla D","year":"2021","unstructured":"Portilla D, Xavier S. Role of intracellular complement activation in kidney fibrosis. Br J Pharmacol. 2021, 178:2880-91. 10.1111\/bph.15408","journal-title":"Br J Pharmacol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0110-2","article-title":"Macrophages: versatile players in renal inflammation and fibrosis","volume":"15","author":"Tang PM","year":"2019","unstructured":"Tang PM, Nikolic-Paterson DJ, Lan HY. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol. 2019, 15:144-58. 10.1038\/s41581-019-0110-2","journal-title":"Nat Rev Nephrol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-022516-034219","article-title":"Macrophages in renal injury and repair","volume":"79","author":"Huen SC","year":"2017","unstructured":"Huen SC, Cantley LG. Macrophages in renal injury and repair. Annu Rev Physiol. 2017, 79:449-69. 10.1146\/annurev-physiol-022516-034219","journal-title":"Annu Rev Physiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00097.x","article-title":"Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat","volume":"57","author":"Forbes JM","year":"2000","unstructured":"Forbes JM, Hewitson TD, Becker GJ, Jones CL. Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat. Kidney Int. 2000, 57:2375-85. 10.1046\/j.1523-1755.2000.00097.x","journal-title":"Kidney Int"},{"key":"ref29","unstructured":"Guide for the Care and Use of Laboratory Animals. Eighth Edition. (2011). Accessed: March 1, 2025: https:\/\/olaw.nih.gov\/policies-laws\/guide-care-use-lab-animals."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2021.05.012","article-title":"ISSCR guidelines for stem cell research and clinical translation: the 2021 update","volume":"16","author":"Lovell-Badge R","year":"2021","unstructured":"Lovell-Badge R, Anthony E, Barker RA, et al.. ISSCR guidelines for stem cell research and clinical translation: the 2021 update. Stem Cell Reports. 2021, 16:1398-408. 10.1016\/j.stemcr.2021.05.012","journal-title":"Stem Cell Reports"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford MM","year":"1976","unstructured":"Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72:248-54. 10.1016\/0003-2697(76)90527-3","journal-title":"Anal Biochem"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr256","article-title":"Effect of captopril treatment on recuperation from ischemia\/reperfusion-induced acute renal injury","volume":"27","author":"Efrati S","year":"2012","unstructured":"Efrati S, Berman S, Hamad RA, Siman-Tov Y, Ilgiyaev E, Maslyakov I, Weissgarten J. Effect of captopril treatment on recuperation from ischemia\/reperfusion-induced acute renal injury. Nephrol Dial Transplant. 2012, 27:136-45. 10.1093\/ndt\/gfr256","journal-title":"Nephrol Dial Transplant"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-014-9545-9","article-title":"A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles","volume":"11","author":"Akyurekli C","year":"2015","unstructured":"Akyurekli C, Le Y, Richardson RB, Fergusson D, Tay J, Allan DS. A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles. Stem Cell Rev Rep. 2015, 11:150-60. 10.1007\/s12015-014-9545-9","journal-title":"Stem Cell Rev Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2020.438","article-title":"Alleviation of renal ischemia\/reperfusion injury by exosomes from induced pluripotent stem cell-derived mesenchymal stem cells","volume":"37","author":"Lim SW","year":"2022","unstructured":"Lim SW, Kim KW, Kim BM, et al.. Alleviation of renal ischemia\/reperfusion injury by exosomes from induced pluripotent stem cell-derived mesenchymal stem cells. Korean J Intern Med. 2022, 37:411-24. 10.3904\/kjim.2020.438","journal-title":"Korean J Intern Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmx016","article-title":"Therapeutic potential of mesenchymal stem cells in acute kidney injury is affected by administration timing","volume":"49","author":"Liu X","year":"2017","unstructured":"Liu X, Cai J, Jiao X, Yu X, Ding X. Therapeutic potential of mesenchymal stem cells in acute kidney injury is affected by administration timing. Acta Biochim Biophys Sin (Shanghai). 2017, 49:338-48. 10.1093\/abbs\/gmx016","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12952","article-title":"Production of complement components by cells of the immune system","volume":"188","author":"Lubbers R","year":"2017","unstructured":"Lubbers R, van Essen MF, van Kooten C, Trouw LA. Production of complement components by cells of the immune system. Clin Exp Immunol. 2017, 188:183-94. 10.1111\/cei.12952","journal-title":"Clin Exp Immunol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-420612","article-title":"Mesenchymal stem cells are injured by complement after their contact with serum","volume":"120","author":"Li Y","year":"2012","unstructured":"Li Y, Lin F. Mesenchymal stem cells are injured by complement after their contact with serum. Blood. 2012, 120:3436-43. 10.1182\/blood-2012-03-420612","journal-title":"Blood"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.12.001","article-title":"Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update","volume":"40","author":"Breda L","year":"2010","unstructured":"Breda L, Nozzi M, De Sanctis S, Chiarelli F. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update. Semin Arthritis Rheum. 2010, 40:53-72. 10.1016\/j.semarthrit.2008.12.001","journal-title":"Semin Arthritis Rheum"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2019.12.003","article-title":"C3 glomerulopathy: pathogenesis and treatment","volume":"27","author":"Ahmad SB","year":"2020","unstructured":"Ahmad SB, Bomback AS. C3 glomerulopathy: pathogenesis and treatment. Adv Chronic Kidney Dis. 2020, 27:104-10. 10.1053\/j.ackd.2019.12.003","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3329\/bmrcb.v33i3.1141","article-title":"Serum complement (C3, C4) levels in patients with acute myocardial infarction and angina pectoris","volume":"33","author":"Giasuddin AS","year":"2007","unstructured":"Giasuddin AS, ElMahdawi JM, ElHassadi FM. Serum complement (C3, C4) levels in patients with acute myocardial infarction and angina pectoris. Bangladesh Med Res Counc Bull. 2007, 33:98-102. 10.3329\/bmrcb.v33i3.1141","journal-title":"Bangladesh Med Res Counc Bull"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2001471","article-title":"A conformational change of complement c5 is required for thrombin-mediated cleavage, revealed by a novel ex vivo human whole blood model preserving full thrombin activity","volume":"207","author":"Nilsson PH","year":"2021","unstructured":"Nilsson PH, Johnson C, Quach QH, et al.. A conformational change of complement c5 is required for thrombin-mediated cleavage, revealed by a novel ex vivo human whole blood model preserving full thrombin activity. J Immunol. 2021, 207:1641-51. 10.4049\/jimmunol.2001471","journal-title":"J Immunol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-011-8239-5","article-title":"Membrane attack by complement: the assembly and biology of terminal complement complexes","volume":"51","author":"Tegla CA","year":"2011","unstructured":"Tegla CA, Cudrici C, Patel S, Trippe R 3rd, Rus V, Niculescu F, Rus H. Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunol Res. 2011, 51:45-60. 10.1007\/s12026-011-8239-5","journal-title":"Immunol Res"},{"key":"ref43","article-title":"The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system","volume":"58","author":"Kitamura H","year":"1986","unstructured":"Kitamura H, Tsuboi M, Nagaki K. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system. Immunology. 1986, 58:459-65.","journal-title":"Immunology"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3791\/54599","article-title":"Phenotypic characterization of macrophages from rat kidney by flow cytometry","volume":"(116)","author":"Rubio-Navarro A","year":"2016","unstructured":"Rubio-Navarro A, Guerrero-Hue M, Mart\u00edn-Fernandez B, et al.. Phenotypic characterization of macrophages from rat kidney by flow cytometry. J Vis Exp. 2016, (116):54599. 10.3791\/54599","journal-title":"J Vis Exp"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.899869","article-title":"Mesenchymal stem cells-derived exosomes ameliorate ischemia\/reperfusion induced acute kidney injury in a porcine model","volume":"10","author":"Huang J","year":"2022","unstructured":"Huang J, Cao H, Cui B, et al.. Mesenchymal stem cells-derived exosomes ameliorate ischemia\/reperfusion induced acute kidney injury in a porcine model. Front Cell Dev Biol. 2022, 10:899869. 10.3389\/fcell.2022.899869","journal-title":"Front Cell Dev Biol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108917","article-title":"The role of IL-10 in kidney disease","volume":"108","author":"Wei W","year":"2022","unstructured":"Wei W, Zhao Y, Zhang Y, Jin H, Shou S. The role of IL-10 in kidney disease. Int Immunopharmacol. 2022, 108:108917. 10.1016\/j.intimp.2022.108917","journal-title":"Int Immunopharmacol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.12.014","article-title":"Circulating IL-6 upregulates IL-10 production in splenic CD4(+) T cells and limits acute kidney injury-induced lung inflammation","volume":"91","author":"Andres-Hernando A","year":"2017","unstructured":"Andres-Hernando A, Okamura K, Bhargava R, et al.. Circulating IL-6 upregulates IL-10 production in splenic CD4(+) T cells and limits acute kidney injury-induced lung inflammation. Kidney Int. 2017, 91:1057-69. 10.1016\/j.kint.2016.12.014","journal-title":"Kidney Int"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.34902","article-title":"Immunotherapy with injectable hydrogels to treat obstructive nephropathy","volume":"102","author":"Soranno DE","year":"2014","unstructured":"Soranno DE, Lu HD, Weber HM, Rai R, Burdick JA. Immunotherapy with injectable hydrogels to treat obstructive nephropathy. J Biomed Mater Res A. 2014, 102:2173-80. 10.1002\/jbm.a.34902","journal-title":"J Biomed Mater Res A"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz0748","article-title":"Extracellular vesicle-encapsulated IL-10 as novel nanotherapeutics against ischemic AKI","volume":"6","author":"Tang TT","year":"2020","unstructured":"Tang TT, Wang B, Wu M, et al.. Extracellular vesicle-encapsulated IL-10 as novel nanotherapeutics against ischemic AKI. Sci Adv. 2020, 6:eaaz0748. 10.1126\/sciadv.aaz0748","journal-title":"Sci Adv"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001006","article-title":"Role of M2 macrophages in sepsis-induced acute kidney injury","volume":"50","author":"Li X","year":"2018","unstructured":"Li X, Mu G, Song C, Zhou L, He L, Jin Q, Lu Z. Role of M2 macrophages in sepsis-induced acute kidney injury. Shock. 2018, 50:233-9. 10.1097\/SHK.0000000000001006","journal-title":"Shock"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara N","year":"2003","unstructured":"Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003, 9:669-76. 10.1038\/nm0603-669","journal-title":"Nat Med"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00103.x","article-title":"Redistribution of cytoplasmic VEGF to the basolateral aspect of renal tubular cells in ischemia-reperfusion injury","volume":"57","author":"Kanellis J","year":"2000","unstructured":"Kanellis J, Mudge SJ, Fraser S, Katerelos M, Power DA. Redistribution of cytoplasmic VEGF to the basolateral aspect of renal tubular cells in ischemia-reperfusion injury. Kidney Int. 2000, 57:2445-56. 10.1046\/j.1523-1755.2000.00103.x","journal-title":"Kidney Int"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00590.2019","article-title":"Pathophysiology of unilateral ischemia-reperfusion injury: importance of renal counterbalance and implications for the AKI-CKD transition","volume":"318","author":"Polichnowski AJ","year":"2020","unstructured":"Polichnowski AJ, Griffin KA, Licea-Vargas H, et al.. Pathophysiology of unilateral ischemia-reperfusion injury: importance of renal counterbalance and implications for the AKI-CKD transition. Am J Physiol Renal Physiol. 2020, 318:F1086-99. 10.1152\/ajprenal.00590.2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00617.2017","article-title":"VEGF therapy for the kidney: emerging strategies","volume":"315","author":"Guise E","year":"2018","unstructured":"Guise E, Chade AR. VEGF therapy for the kidney: emerging strategies. Am J Physiol Renal Physiol. 2018, 315:F747-51. 10.1152\/ajprenal.00617.2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017070781","article-title":"Clinical translation of mesenchymal stromal cell therapies in nephrology","volume":"29","author":"Perico N","year":"2018","unstructured":"Perico N, Casiraghi F, Remuzzi G. Clinical translation of mesenchymal stromal cell therapies in nephrology. J Am Soc Nephrol. 2018, 29:362-75. 10.1681\/ASN.2017070781","journal-title":"J Am Soc Nephrol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1049\/nbt2.12071","article-title":"Bone marrow mesenchymal stem cell-derived exosomes improve renal fibrosis by reducing the polarisation of M1 and M2 macrophages through the activation of EP2 receptors","volume":"16","author":"Lu Y","year":"2022","unstructured":"Lu Y, Yang L, Chen X, Liu J, Nie A, Chen X. Bone marrow mesenchymal stem cell-derived exosomes improve renal fibrosis by reducing the polarisation of M1 and M2 macrophages through the activation of EP2 receptors. IET Nanobiotechnol. 2022, 16:14-24. 10.1049\/nbt2.12071","journal-title":"IET Nanobiotechnol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8814574","article-title":"Comparison of the effects of mesenchymal stem cells with their extracellular vesicles on the treatment of kidney damage induced by chronic renal artery stenosis","volume":"2020","author":"Ishiy CS","year":"2020","unstructured":"Ishiy CS, Ormanji MS, Maquigussa E, Ribeiro RS, da Silva Novaes A, Boim MA. Comparison of the effects of mesenchymal stem cells with their extracellular vesicles on the treatment of kidney damage induced by chronic renal artery stenosis. Stem Cells Int. 2020, 2020:8814574. 10.1155\/2020\/8814574","journal-title":"Stem Cells Int"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1166\/jbn.2021.3155","article-title":"Umbilical cord mesenchymal stem cell exosomes alleviate the progression of kidney failure by modulating inflammatory responses and oxidative stress in an ischemia-reperfusion mice model","volume":"17","author":"Zhang Y","year":"2021","unstructured":"Zhang Y, Wang C, Bai Z, Li P. Umbilical cord mesenchymal stem cell exosomes alleviate the progression of kidney failure by modulating inflammatory responses and oxidative stress in an ischemia-reperfusion mice model. J Biomed Nanotechnol. 2021, 17:1874-81. 10.1166\/jbn.2021.3155","journal-title":"J Biomed Nanotechnol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2020.01.011","article-title":"Pathophysiology of AKI to CKD progression","volume":"40","author":"Sato Y","year":"2020","unstructured":"Sato Y, Takahashi M, Yanagita M. Pathophysiology of AKI to CKD progression. Semin Nephrol. 2020, 40:206-15. 10.1016\/j.semnephrol.2020.01.011","journal-title":"Semin Nephrol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2021.09.006","article-title":"Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy","volume":"28","author":"Krampera M","year":"2021","unstructured":"Krampera M, Le Blanc K. Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy. Cell Stem Cell. 2021, 28:1708-25. 10.1016\/j.stem.2021.09.006","journal-title":"Cell Stem Cell"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18091852","article-title":"Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine","volume":"18","author":"Vizoso FJ","year":"2017","unstructured":"Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci. 2017, 18:1852. 10.3390\/ijms18091852","journal-title":"Int J Mol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/366080-effects-of-small-extracellular-vesicles-derived-from-mesenchymal-stromal-cells-on-acute-kidney-injury-a-rat-ischemia-reperfusion-model","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T17:00:24Z","timestamp":1747674024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/366080-effects-of-small-extracellular-vesicles-derived-from-mesenchymal-stromal-cells-on-acute-kidney-injury-a-rat-ischemia-reperfusion-model"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":61,"URL":"https:\/\/doi.org\/10.7759\/cureus.84411","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,19]]}}}